Volume 10, Number 3, 163-167, DOI: 10.1007/s12094-008-0174-0

Published in partnership with

Logo

Superoxidase dismutase (SOD) topical use in oncologic patients: treatment of acute cutaneous toxicity secondary to radiotherapy

Álvaro Manzanas García, María Concepción López Carrizosa, Carmen Vallejo Ocaña, Pilar Samper Ots, José María Delgado Pérez, Emilia Carretero Accame, Pilar Gómez-Serranillos and Luis de la Morena del Valle

View Related Documents

Abstract

Objective  

The objective of this study is to evaluate the efficiency of SOD applied topically in oncologic patients affected by acute radiodermatitis.

Materials and method  

This study includes 57 patients who showed a dermatitis grade 2 or superior; they were administered SOD ointment b.i.d. (40 mg, weekly) and follow-up continued for 12 weeks.

Results  

At the end of radiotherapy, 77.1% of the patients ameliorated completely or partially, and at the end of the 12-week period 100% of patients were free of toxicity. No acute toxicity relapses were reported. Response time reduced during radiotherapy, as well as the treatment time at the end of it.

Conclusions  

The employment of SOD topically is efficient in the treatment of radiodermatitis, which is an acute side effect of radiotherapy.

Keywords  Superoxide dismutase - Radiodermatitis - Orgotein - Topical route

Fulltext Preview

Image of the first page of the fulltext document